Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Danaher Corporation
Danaher Corporation News
Danaher Corporation Quantitative Score
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Danaher Corporation Earnings & Revenue
Danaher Corporation Financials
Table Compare
Compare DHR metrics with: | |||
---|---|---|---|
Earnings & Growth | DHR | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | DHR | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | DHR | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | DHR | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Danaher Corporation Income
Danaher Corporation Balance Sheet
Danaher Corporation Cash Flow
Danaher Corporation Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Buy |
Return on Equity | Buy |
Return on Assets | Buy |
Debt/Equity Ratio | Sell |
Price/Earnings Ratio | Strong Sell |
Price/Book Ratio | Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Danaher Corporation Dividends
Yield (TTM) | Dividend (TTM) | |
---|---|---|
Infinity% | 1.0500 |
Payment Date | Dividend | Frequency |
---|---|---|
2024-10-25 | 0.27 | Quarterly |
2024-07-26 | 0.27 | Quarterly |
2024-04-26 | 0.27 | Quarterly |
2024-01-26 | 0.24 | Quarterly |
2023-10-27 | 0.27 | Quarterly |
Danaher Corporation Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Danaher Corporation Executives
Name | Role |
---|---|
Mr. Rainer M. Blair | President, Chief Executive Officer & Director |
Mr. Joakim Weidemanis | Executive Officer |
Mr. Matthew R. McGrew | Chief Financial Officer & Executive Vice President |
Dr. Jose-Carlos Gutierrez-Ramos Ph.D. | Senior Vice President & Chief Science Officer |
Mr. Brian W. Ellis | Senior Vice President, General Counsel & Chief Compliance Officer |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. Rainer M. Blair | President, Chief Executive Officer & Director | Male | 1964 | 5.33M |
Mr. Joakim Weidemanis | Executive Officer | Male | 1969 | 2.76M |
Mr. Matthew R. McGrew | Chief Financial Officer & Executive Vice President | Male | 1972 | 2.56M |
Dr. Jose-Carlos Gutierrez-Ramos Ph.D. | Senior Vice President & Chief Science Officer | 1962 | 2.09M | |
Mr. Brian W. Ellis | Senior Vice President, General Counsel & Chief Compliance Officer | Male | 1967 | 1.93M |
Danaher Corporation Insider Trades
Date | 26 Aug |
Name | Couchara Georgeann |
Role | SVP, Human Resources |
Transaction | Disposed |
Type | S-Sale |
Shares | 952 |
Date | 31 Jul |
Name | Blair Rainer |
Role | President & CEO |
Transaction | Disposed |
Type | S-Sale |
Shares | 9007 |
Date | 1 Aug |
Name | Blair Rainer |
Role | President & CEO |
Transaction | Disposed |
Type | G-Gift |
Shares | 30765 |
Date | 1 Aug |
Name | FILLER LINDA |
Role | Director |
Transaction | Acquired |
Type | M-Exempt |
Shares | 3928 |
Date | 1 Aug |
Name | FILLER LINDA |
Role | Director |
Transaction | Disposed |
Type | S-Sale |
Shares | 3928 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
26 Aug | Couchara Georgeann | SVP, Human Resources | Disposed | S-Sale | 952 |
31 Jul | Blair Rainer | President & CEO | Disposed | S-Sale | 9007 |
1 Aug | Blair Rainer | President & CEO | Disposed | G-Gift | 30765 |
1 Aug | FILLER LINDA | Director | Acquired | M-Exempt | 3928 |
1 Aug | FILLER LINDA | Director | Disposed | S-Sale | 3928 |